P

Prothena Corp

D
PRTA
USD
-1.13
(-6.5583%)
Market Closed
13,259.00
حجم التداول
-2.245
الربح لكل سهم
-
العائد الربحي
-17.127660
P/E
865,863,554.50
حجم السوق
اليوم
-6.5583%
1 اسبوع
-7.895%
1 شهر
-7.098%
6 اشهر
-22.222%
12 اشهر
-54.404%
بداية السنة
-55.721%
كل الوقت
-73.176%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Prothena Corp

Sector:
Healthcare
Industry:
Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
هل تحتاج مساعدة او لديك استفسار؟